| Literature DB >> 19924133 |
Sayaka Shibata1, Yayoi Tada, Naoko Kanda, Kiyoko Nashiro, Masahiro Kamata, Masaru Karakawa, Tomomitsu Miyagaki, Hiromichi Kai, Hidehisa Saeki, Yuji Shirakata, Shinichi Watanabe, Kunihiko Tamaki, Shinichi Sato.
Abstract
The immunological significance of IL-27 has been reported and discussed in various Th1/Th17-mediated inflammatory diseases. However, its importance in psoriasis is unknown. We investigated pathophysiological roles of IL-27 in psoriasis in this study. Serum IL-27 levels in psoriatic patients were significantly higher than those in healthy controls, and correlated with disease severity and serum IFN-gamma levels. An immunohistochemical analysis revealed the infiltration of IL-27-secreting cells in the papillary dermis of psoriatic skin lesions but not in skin lesions with atopic dermatitis or normal skin. Furthermore, IL-27 alone greatly induced in vitro CXCL9, CXCL10, and CXCL11 production and tyrosine phosphorylation of signal transducer and activator of transcription 1 in normal human keratinocytes, while it suppressed the tumor necrosis factor-alpha-induced production of IL-1alpha and CCL20. These results indicate that IL-27 may promote the onset of psoriasis, while it may simultaneously attenuate the expanded inflammation in this disease. Our results implicate potential therapeutic effects of IL-27 for psoriasis.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19924133 DOI: 10.1038/jid.2009.349
Source DB: PubMed Journal: J Invest Dermatol ISSN: 0022-202X Impact factor: 8.551